Neovasc Announces Publication of Peer-Reviewed Article in EuroIntervention

REDUCER I Study Shows Improvement in Chest Pain Symptoms   VANCOUVER and MINNEAPOLIS - (NewMediaWire) - December 17, 2020 - Neovasc Inc. (Neovasc or the Company) (Nasdaq, TSX: NVCN) announced today thatEuroIntervention, the official journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI), has...

Read More

Neovasc Announces First Neovasc Reducer Implants in France

VANCOUVER and MINNEAPOLIS - (NewMediaWire) - December 15, 2020 - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) announced today that it has completed the first three Neovasc Reducer(TM) (Reducer) implants in France. The implants are an important step for Neovasc as the Company...

Read More

Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

VANCOUVER and MINNEAPOLIS - (NewMediaWire) - December 10, 2020 - Neovasc, Inc. (Neovasc or the Company) (NASDAQ,TSX:NVCN), announced today that it has received written notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is not in compliance with...

Read More